mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |